PJAM reports nine-month net profit attributable to shareholders of $1.85 billion

November 14, 2022

PANJAM Investment Limited (PJAM) for nine months ended September 30, 2022 reported a 46% decline in total income to $1.56 billion (2021: $2.89 billion). For the quarter, it declined 27% to close at $503.75 million (2021: $694.25 million).  Of the nine-month total income:

  • Investment loss amounted to $362.31 million (2021: income of $1.28 billion), which PJAM noted was driven by unrealized losses in their portfolio of local and overseas securities, despite higher dividend and interest income.
  • Property income grew 3% to $1.56 billion (2021: $1.51 billion); PJAM noted that this was “due to annual rental rate adjustments and revaluation gains”.
  • Hotel income amounted to $255.55 million (2021: nil)
  • Other income grew 2% to $101.10 million (2021: $99.03 million)

Operating expenses amounted to $1.90 billion (2021: $1.33 billion), 43% more than its total a year prior, because of “costs related to the opening of the ROK Hotel as well as overarching inflationary pressures” according to PJAM. For the quarter, it increased 67% to $763.36 million (2021: $458.02 million).

Impairment losses declined to $11.15 million (2021: $11.88 million).

Consequently, operating loss amounted to $351.27 million (2021: profit of $1.55 billion), while for the quarter, it amounted to $275.32 million (2021: profit of $206.68 million).

Finance costs for the period rose 10% to $754.40 million (2021: $688.08 million).

There was no gain on disposal of associated company for the period (2021: $25.53 million), while the share of results of associated companies declined 24% to $3.08 billion (2021: $4.07 billion). PJAM noted that this was mainly driven by Sagicor results, which declined 22%.

Profit before taxation declined 24% to $1.98 billion (2021: $4.95 billion). Following taxation charge of $106.62 million (2021: $138.81 million), net profit amounted to $1.87 billion (2021: $4.81 billion). Net profit for the quarter amounted to $688.23 million (2021: $2.47 billion).

Net profit attributable to shareholders amounted to $1.85 billion (2021: $4.80 billion), a 61% decline year over year. For the quarter, it amounted to $681.79 million (2021: $2.47 billion).

Total comprehensive loss amounted to $2.02 billion (2021: income of $4.06 billion). For the quarter, total comprehensive income was $504.57 million (2021: $2.23 billion).

Consequently, earnings per share (EPS) for the period amounted to $1.74 (2021: $4.50), while for the quarter, EPS amounted to $0.64 (2021: $2.32). The trailing twelve-month EPS was $3.99. The number of shares used in the calculation is 1,066,159,890 units. PJAM’s stock last traded on November 11, 2022 at $54.00 with a corresponding P/E of 13.52 times.

Balance Sheet at a glance:

As at September 30, 2022, PJAM had assets totaling $65.39 billion (2021: $66.39 billion).  This growth was mainly attributed to a 70% increase in ‘Prepayment and miscellaneous assets’ to 3.21 billion (2021: $1.89 billion).

Shareholders Equity amounted to $48.86 billion (2021: $50.73 billion) with a book value per share of $45.82 (2021: $47.58).



Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.